MedTrace Logo

Verapamil in Supraclavicular Brachial Plexus Block

NCT05183997 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2022-01-11

No results posted yet for this study

Summary

Supraclavicular brachial plexus block (SCBPB) is the common approach to provide surgical anesthesia of upper limb. The effects of single-injection brachial plexus nerve blocks recede after several hours unmasking the moderate to- severe pain of the surgical insult.

Conditions

  • Regional Anesthesia Morbidity

Interventions

DIAGNOSTIC_TEST

complete blood count

laboratory test

DIAGNOSTIC_TEST

prothrombin time

laboratory test

DIAGNOSTIC_TEST

prothrombin concentration

laboratory test

DRUG

Verapamil

drug will be add to prolong the effect of regional block

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Study Design

Allocation
NON_RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-01-31
Primary Completion
2023-02-28
Completion
2023-02-28

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05183997 on ClinicalTrials.gov